CTSH vs IBM: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: CTSH is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. CTSH and IBM share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined CTSH and IBM exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Cognizant Technology Solutions is one of the largest global IT services and consulting firms, with roughly 357,600 employees (as of April 2026) and a delivery model centered on India-based talent serving mostly North American and European clients. It builds, runs, and modernizes software and business processes across four segments, Health Sciences, Financial Services, Products and Resources, and Communications, Media and Technology, and is increasingly positioning around generative AI, cloud migration, and data services (including a roughly $600 million acquisition of AI-infrastructure provider Astreya).

Full CTSH guide

International Business Machines (IBM) is one of the oldest and largest technology companies, now focused on enterprise software, consulting, and infrastructure. Its strategy centers on hybrid cloud and AI, anchored by Red Hat (the open-source software it acquired) and its watsonx AI platform. IBM's Software segment sells automation, data, security, and hybrid-cloud software, increasingly on a recurring subscription basis. Consulting provides large-scale technology and business services, helping enterprises modernize and adopt AI. Infrastructure includes IBM's mainframe systems (the zSystems that run mission-critical workloads for banks and large enterprises) and related storage. IBM makes money from a mix of recurring software, services contracts, and hardware tied to mainframe cycles. After years of slow growth, IBM has repositioned around hybrid cloud and AI, divested legacy businesses (spinning off Kyndryl), and emphasized recurring revenue and free cash flow. Founded in 1911 and headquartered in Armonk, New York, IBM is a mature, dividend-paying enterprise technology company.

Full IBM guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• CTSH drivers: AI-led services and deal momentum; Margin expansion via Project Leap.
• IBM drivers: Hybrid cloud with Red Hat; Enterprise AI with watsonx.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The core risk is that AI automation erodes the labor-arbitrage economics of traditional IT services, pressuring pricing and headcount-linked revenue over time. For IBM, iBM is a mature company that has struggled to grow revenue much above low single digits, so the story depends on the higher-growth software and AI mix offsetting slower legacy areas.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick CTSH if you believe its drivers more; IBM if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the CTSH and IBM guides.

CTSH. As of July 2026, CTSH's valuation is notably low for a profitable large-cap, reflecting the market's skepticism about IT-services growth in an AI world after the stock fell sharply during 2026. First-quarter 2026 revenue rose 5.8% year over year to $5.413 billion, and full-year 2026 revenue is guided to roughly $22.1 billion to $22.6 billion. Figures are approximate and change with each quarterly report and share-price move.

IBM. IBM trades at a valuation that reflects a mature enterprise technology company with modest revenue growth but strong, dependable free cash flow and a high dividend. The market increasingly prices in the higher-growth software and AI mix and the hybrid-cloud strategy, which has lifted sentiment from IBM's lower-growth past. It remains valued more as a cash-flow and income story than a high-growth name.

Headline figures (approximate, JULY 2026): CTSH shows revenue (ttm) ~$21.4B, net income (ttm) ~$2.2B, market cap ~$25B, trailing p/e ~11-12x; IBM shows revenue (ttm) ~$63 billion, operating margin ~15%, net income (ttm) ~$7 billion, p/e (ttm) ~25x.

CTSH and IBM are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined CTSH and IBM exposure against your real portfolio. It is not an investment adviser.